Morbidity and Volumetric Progression in Juvenile Nasopharyngeal Angiofibroma in a Long-Term Follow-Up.

J Neurol Surg B Skull Base

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Switzerland.

Published: December 2018

 We compare the open and transnasal approaches for the excision of juvenile nasopharyngeal angiofibromas regarding the rate of morbidity, and residual tumor and its symptomatic recurrence over time. In addition, we present volumetric measurements of juvenile nasopharyngeal angiofibromas over time.  All surgically treated patients of our institution were reviewed back to 1969 for type of surgery, residual tumor by magnetic resonance imaging (MRI)-based volumetry, recurrence, and morbidity. We performed a prospective clinical and radiological follow-up on reachable patients.  In total, 40 patients were retrievable from our records. We were able to follow up on 13 patients after a mean of 15.7 years since surgery (range: 1-47 years). Patients operated by the open approach had a higher rate of postoperative complications and thus a higher morbidity than endoscopic patients (4/4 vs 3/9;  = 0.007), although tumor sizes were equal among groups (  = 0.12). Persisting tumor was noted in 3/4 and 4/9 (  = 0.56) patients, respectively. The corresponding mean volumes of residual tumors were 16.2 ± 14.4 cm and 10.8 ± 6.6 cm (  = 0.27). No progression could be noted in endoscopically treated patients (  = 0.24, mean time between scans 2 years).  Our analysis shows that the endoscopic approach results in less morbidity. The open approach does not guarantee freedom from persisting tumor tissue. Age seems to be a most important risk factor for the conversion of an asymptomatic persistence into a symptomatic recurrence.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239873PMC
http://dx.doi.org/10.1055/s-0038-1635255DOI Listing

Publication Analysis

Top Keywords

juvenile nasopharyngeal
12
nasopharyngeal angiofibromas
8
residual tumor
8
symptomatic recurrence
8
patients
8
treated patients
8
open approach
8
persisting tumor
8
morbidity
5
tumor
5

Similar Publications

Objective: The objective of this study was to discuss the characteristics of intracranial extension in patients with juvenile nasopharyngeal angiofibroma (JNA) and propose and an algorithm for its management.

Methods: A retrospective chart review of all patients with JNA who underwent operations between January 2013 and January 2023 was done, and those cases with intracranial extension categorized as stage IIIb, IVa, and IVb according to the Andrews modification of the Fisch staging classification were included in the study. Data were collected about age at presentation, symptoms, radiological findings, routes of intracranial extension, therapeutic management, and follow-up.

View Article and Find Full Text PDF

Juvenile nasopharyngeal angiofibroma (JNA) is a rare, locally aggressive, highly vascularized benign tumor classically found in males from 13 to 20 years old. The most common clinical presentations are recurrent epistaxis and nasal congestion. Imaging plays a significant role in differentiating and determining the extension of nasopharyngeal lesions.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzes 12 cases of juvenile nasopharyngeal angiofibroma (JNA) in young males treated at a hospital between 2015 and 2020, focusing on the effectiveness of endoscopic plasma resection.
  • Preoperative imaging and selective artery embolization were performed, and patients were followed for at least 30 months to monitor outcomes.
  • Results showed clear vision, minimal bleeding, quick recovery, and no tumor recurrence, suggesting that this technique is a safe and effective treatment for JNA.
View Article and Find Full Text PDF

Objectives: Juvenile nasopharyngeal angiofibroma is an uncommon tumour primarily seen in young males. It is characterized by its vascular nature and aggressive growth pattern, presenting a significant surgical challenge. Endoscopic sinonasal surgery has become the treatment of choice, reducing both morbidity and blood loss, as well as recurrence rates.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!